149 related articles for article (PubMed ID: 20431065)
1. Chemokine ligand 2 genetic variants, serum monocyte chemoattractant protein-1 levels, and the risk of coronary artery disease.
van Wijk DF; van Leuven SI; Sandhu MS; Tanck MW; Hutten BA; Wareham NJ; Kastelein JJ; Stroes ES; Khaw KT; Boekholdt SM
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1460-6. PubMed ID: 20431065
[TBL] [Abstract][Full Text] [Related]
2. Monocyte chemoattractant protein-1 gene (MCP-1) polymorphisms are associated with risk of premature coronary artery disease in Mexican patients from the Genetics of Atherosclerotic Disease (GEA) study.
Angeles-Martínez J; Posadas-Sánchez R; Álvarez-León E; Villarreal-Molina T; Cardoso-Saldaña G; Fragoso JM; Juárez-Rojas JG; Medina-Urrutia A; Posadas-Romero C; Vargas-Alarcón G
Immunol Lett; 2015 Oct; 167(2):125-30. PubMed ID: 26277553
[TBL] [Abstract][Full Text] [Related]
3. The Frequency of Monocyte Chemoattractant Protein-1 Gene Polymorphism in Obstructive Sleep Apnea Syndrome.
Kerget B; Araz O; Erdem HB; Akgün M
Lung; 2019 Oct; 197(5):585-592. PubMed ID: 31388753
[TBL] [Abstract][Full Text] [Related]
4. Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis.
Nyquist PA; Winkler CA; McKenzie LM; Yanek LR; Becker LC; Becker DM
Cerebrovasc Dis; 2009; 28(2):124-30. PubMed ID: 19506371
[TBL] [Abstract][Full Text] [Related]
5. Impact of MCP-1 and CCR-2 gene polymorphisms on coronary artery disease susceptibility.
Lin HL; Ueng KC; Hsieh YS; Chiang WL; Yang SF; Chu SC
Mol Biol Rep; 2012 Sep; 39(9):9023-30. PubMed ID: 22752804
[TBL] [Abstract][Full Text] [Related]
6. Effect of monocyte chemoattractant protein-1 (MCP-1) gene polymorphism in Turkish patients with premature coronary artery disease.
Cam SF; Sekuri C; Sagcan A; Ercan E; Tengiz I; Alioglu E; Berdeli A
Scand J Clin Lab Invest; 2008; 68(8):801-5. PubMed ID: 18651322
[TBL] [Abstract][Full Text] [Related]
7. CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study.
McDermott DH; Yang Q; Kathiresan S; Cupples LA; Massaro JM; Keaney JF; Larson MG; Vasan RS; Hirschhorn JN; O'Donnell CJ; Murphy PM; Benjamin EJ
Circulation; 2005 Aug; 112(8):1113-20. PubMed ID: 16116069
[TBL] [Abstract][Full Text] [Related]
8. Association of monocyte chemoattractant protein-1 -2518 polymorphism with metabolic syndrome in a South Indian cohort.
Kaur S; Panicker SR; James T; Sarma PS; Thankappan KR; Kartha CC
Metab Syndr Relat Disord; 2009 Jun; 7(3):193-8. PubMed ID: 19450143
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein, fatal and nonfatal coronary artery disease, stroke, and peripheral artery disease in the prospective EPIC-Norfolk cohort study.
van Wijk DF; Boekholdt SM; Wareham NJ; Ahmadi-Abhari S; Kastelein JJ; Stroes ES; Khaw KT
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2888-94. PubMed ID: 24072695
[TBL] [Abstract][Full Text] [Related]
10. Assessment of genetic effects of polymorphisms in the MCP-1 gene on serum MCP-1 levels and myocardial infarction in Japanese.
Iwai N; Kajimoto K; Kokubo Y; Okayama A; Miyazaki S; Nonogi H; Goto Y; Tomoike H
Circ J; 2006 Jul; 70(7):805-9. PubMed ID: 16799229
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of monocyte chemoattractant protein-1 and all-cause and cardiovascular mortality among patients with coronary artery disease.
Ding D; Su D; Li X; Li Z; Wang Y; Qiu J; Lin P; Zhang Y; Guo P; Xia M; Li D; Yang Y; Hu G; Ling W
PLoS One; 2015; 10(3):e0120633. PubMed ID: 25786118
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine concentration in coronary artery disease: Influence of three common single nucleotide polymorphisms.
Bickel C; Schnabel RB; Zengin E; Lubos E; Rupprecht H; Lackner K; Proust C; Tregouet D; Blankenberg S; Westermann D; Sinning C
Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):168-175. PubMed ID: 27773468
[TBL] [Abstract][Full Text] [Related]
13. Association of monocyte chemoattractant protein-1 (MCP-1)-2518A>G polymorphism with susceptibility to coronary artery disease: a meta-analysis.
Bai XY; Li S; Wang M; Qu X; Hu G; Xu Z; Chen M; He GW; Wu H
Ann Hum Genet; 2015 May; 79(3):173-87. PubMed ID: 25875728
[TBL] [Abstract][Full Text] [Related]
14. A monocyte chemoattractant protein-1 gene polymorphism is not associated with coronary artery disease in a Han Chinese population.
Zhang X; Han Y; Kang J; Yan C
Clin Chim Acta; 2009 May; 403(1-2):241-3. PubMed ID: 19332042
[TBL] [Abstract][Full Text] [Related]
15. A monocyte chemoattractant protein-1 gene polymorphism is associated with occult ischemia in a high-risk asymptomatic population.
Kim MP; Wahl LM; Yanek LR; Becker DM; Becker LC
Atherosclerosis; 2007 Aug; 193(2):366-72. PubMed ID: 16934270
[TBL] [Abstract][Full Text] [Related]
16. Monocyte chemoattractant protein-1-2518 G/A polymorphism, plasma levels, and premature stable coronary artery disease.
Zhong C; Luzhan Z; Genshan M; Jiahong W; Xiaoli Z; Qi Q
Mol Biol Rep; 2010 Jan; 37(1):7-12. PubMed ID: 19247801
[TBL] [Abstract][Full Text] [Related]
17. Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population.
Antiochos P; Marques-Vidal P; Virzi J; Pagano S; Satta N; Hartley O; Montecucco F; Mach F; Kutalik Z; Waeber G; Vollenweider P; Vuilleumier N
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2342-2349. PubMed ID: 29074586
[TBL] [Abstract][Full Text] [Related]
18. Association of -2518A>G promoter polymorphism in the monocyte chemoattractant protein-1 (MCP-1) gene with type 2 diabetes and coronary artery disease.
Kaur R; Matharoo K; Arora P; Bhanwer AJ
Genet Test Mol Biomarkers; 2013 Oct; 17(10):750-5. PubMed ID: 23930970
[TBL] [Abstract][Full Text] [Related]
19. MCP1 -2518 polymorphism and chronic obstructive pulmonary disease in Taiwanese men.
Liu SF; Wang CC; Fang WF; Chen YC; Lin MC
Exp Lung Res; 2010 Jun; 36(5):277-83. PubMed ID: 20497022
[TBL] [Abstract][Full Text] [Related]
20. Genetically Determined Levels of Circulating Cytokines and Risk of Stroke.
Georgakis MK; Gill D; Rannikmäe K; Traylor M; Anderson CD; Lee JM; Kamatani Y; Hopewell JC; Worrall BB; Bernhagen J; Sudlow CLM; Malik R; Dichgans M
Circulation; 2019 Jan; 139(2):256-268. PubMed ID: 30586705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
